Inventor
Daniel Patrick Walker
Inventor
Kalamazoo, MI, US
Overview
Patents· 22 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds46%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
A61KPreparations for medical, dental or toiletry purposes12%
C07CAcyclic or carbocyclic compounds7%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry2%
PatentTitleYear
10,815,213Bruton's tyrosine kinase inhibitors202010,807,9363,6-dichlorosalicylic acid compounds and related synthetic processes202010,745,376Processes for the preparation of heteroaryl carboxylic acids202010,519,0923,6-dichlorosalicylic acid compounds and related synthetic processes201910,266,513Bruton's tyrosine kinase inhibitors201910,239,857Processes for the preparation of 2-thiophenecarbonyl chloride20199,856,201'3,6-dichlorosalicylic acid compounds and related synthetic processes'20187,829,572'Pyrido[4,3-d]pyrimidin-4(3H)-one derivatives as calcium receptor antagonists'20107,176,198'1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease'20077,001,900'Azabicyclic compounds for the treatment of disease'20066,951,868'Azabicyclic-phenyl-fused-heterocyclic compounds for treatment of disease'20056,919,359'Azabicyclic-substituted-heteroaryl compounds for the treatment of disease'20056,911,543'Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease'20056,894,042'Azabicyclic compounds for the treatment of disease'20056,869,946'Substituted azabicyclic moieties for the treatment of disease'20056,858,613'Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease'20056,852,716'Substituted-aryl compounds for treatment of disease'20056,849,620'N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease'20056,828,330'Quinuclidine-substituted hetero-bicyclic aromatic compounds for the treatment of disease'20045,965,595'2-Imidazolinylamino heterocyclic compounds useful as alpha-2 adrenoceptor agonists'19995,914,342'2-imidazolinylamino heterocyclic compounds useful as alpha-2 adrenoceptor agonists'19995,663,189'2-imidazolinylamino heterocyclic compounds useful as alpha-2 adrenoceptor agonists'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997–1999Patents assigned to PROCTER & GAMBLE (3)· patent assignee history
1997–1999Based in Bloomington, IN, US· patent location history
2004–2005Patents assigned to UPJOHN CO (2)· patent assignee history
2004–2007Based in Kalamazoo, MI, US· patent location history
2005–2020Patents assigned to PFIZER (12)· patent assignee history
2010Based in Chesterfield, MO, US· patent location history
2018–2020Patents assigned to MONSANTO TECHNOLOGY LLC (5)· patent assignee history
2018–2020Based in Augusta, MO, US· patent location history
2019Based in St. Charles, MO, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PFIZER | 12 | 2005–2020 |
| MONSANTO TECHNOLOGY LLC | 5 | 2018–2020 |
| PROCTER & GAMBLE | 3 | 1997–1999 |
| UPJOHN CO | 2 | 2004–2005 |
Locations
| Location | Patents | Span |
|---|---|---|
| Kalamazoo, MI, US | 10 | 2004–2007 |
| Augusta, MO, US | 6 | 2018–2020 |
| Bloomington, IN, US | 3 | 1997–1999 |
| St. Charles, MO, US | 1 | 2019 |
| Chesterfield, MO, US | 1 | 2010 |